TCH-346
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TCH-346, covering 2011-11-24 to 2011-11-24. Get the full timeline:
Most recent: Clinical Trial Update: A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis [Phase 2]